Male prostate problems

Jim’s Story- Chlamydia Pneumoniae and Chronic Fatigue/Fibromyalgia

Submitted by Jim K on Sat, 2005-09-17 20:56

The Tunnel of IllnessI want to update my story on the front end so readers know even before reading the "agony post" how much benefit I've gotten from the treatment. It is August 26th, 2006. Coming up on two years I've been on the Combined Antibiotic Protocol (CAP) for Chlamydia pneumoniae (Cpn). A recent forum poster asked if anyone with CFS has improved on the CAP. My response:

Damned right I'm getting better!When I started the CAP I was in a 2 year slide after 25 years of CFS, then added FMS. For many years I'd struggled and somehow maintained a semblance of a life. Then over 2 years my pain, brain fog, restricted functioning, etc. slid to a point where I had to stop traveling and could for the first time see the possibility that I would become bedridden eventually.

Essential Observations by Dr. Charles Stratton on Chlamydia Pneumoniae Infection and Disease

Submitted by Jim K on Tue, 2006-09-12 16:57

I am very excited to present the following article that summarizes Dr. Stratton's recent observations on Chlamydia pneumoniae infection. Putting it together has contributed greatly to my own understanding of Cpn as well as to my appreciation of Dr. Stratton's generosity with his time, and his great depth of knowledge of this area. Thanks to him for his contribution. Jim K Recent observations by Dr Recent observations by Dr. Charles Stratton on Chlamydia Pneumoniae (Cpn) Infection

Prostatitis, Prostate Cancer and Chlamydia Pneumoniae

Submitted by Jim K on Wed, 2006-09-06 16:31

Stratton et al found evidence of Cpn in interstitial cystitis (IC) in a study which is listed in our research pages. In a recent web excursion I found this researcher's page which describes a number of studies finding quite high rates of Cpn in prostatitis, BHP, and even prostate cancer: research looks solid to me. Worth taking a look. 

Chlamydia pneumoniae... in prostate pathologies.

Submitted by Jim K on Wed, 2005-08-24 20:23

Chlamydia pneumoniae as an impacting emerging pathogen in prostate pathologies.

S. Mazzoli,1 A. Salvi,1 F. Guercini,2 M. Marongiu,1 A. Raugei 3 1 Centro MST, Ospedale S.M. Annunziata, Firenze, Italy 2 Istituto di Urologia, Universita' degli Studi, Perugia, Italy 3 Istituto di Urologia, Universita' degli Studi, Firenze, Italy

Chlamydia pneumoniae (C.p.) is one of the newest pathogens of the respiratory tract in humans. Every year almost 10% communicable pneumonitis are caused by this microorganism. The seroprevalence of C.p. in normal populations is high, estimated to be 50% at the age of fifthly, confirming its wide diffusion. Recently, C.p. has been connected with coronary chronic disease and myocardial infarction. Very recently C.p. has been found in patients with interstitial cystitis, a condition related to prostatitis.